Dados B3Stocks › BRFS3 PT

Consumo não-Cíclico

BRFS3 — BRF S.A.

CNPJ 01.838.723/0001-27 · listed classes: BRFS3 · CVM code 16292

9.6P/E
2.0P/B
3.8EV/EBITDA
31.8%FCF yield
23.2%ROE 2025
19.5%ROIC 2025
P/E, P/B and EV/EBITDA priced at the session of 2025-02-26 (R$ 19.01), the first one after the 2024 filing became public on 2025-02-26 — point-in-time, not the 31 December price.

The full history, year by year

The arrow opens the path from the figure down to the line in the regulator's file. A cell with ! carries a caveat; a dash is a withheld figure — hover for the reason. Nothing is hidden.

indicator2010201120122013201420152016201720182019202020212022202320242025
ROE 5.9%!9.9%5.7%7.3%14.7%21.4%-2.9%-9.8%-49.0%4.0%16.8%4.9%-32.1%-15.5%21.4%23.2%
ROIC 6.8%!9.7%6.8%!8.1%14.2%19.4%!5.1%!1.9%!-0.5%!12.7%!12.5%!8.0%!-0.3%!2.1%!19.5%19.5%
ROA 2.9%!4.7%2.7%3.4%6.5%8.2%-0.9%-2.5%-10.2%0.7%3.0%0.8%-5.5%-3.2%6.2%5.0%
Gross margin 25.3%25.9%22.6%24.8%29.3%31.3%22.3%20.6%16.1%24.1%24.0%21.0%15.1%16.5%25.8%25.2%
EBIT margin 6.5%7.8%4.9%6.4%12.0%13.1%5.4%2.2%-0.7%8.8%7.2%6.2%-0.3%1.6%11.1%10.2%
Net margin 3.5%5.3%2.9%3.5%7.7%9.7%-1.1%-3.3%-14.8%0.9%3.5%0.9%-5.8%-3.5%6.0%5.1%
Revenue growth (1y) 13.3%10.9%7.0%4.4%11.0%4.8%-0.8%6.6%10.8%18.0%22.5%11.3%-0.4%14.5%6.0%
Revenue growth (5y CAGR) 7.3%5.6%3.3%1.7%2.9%4.2%7.5%13.7%12.2%12.9%10.5%
Net debt/EBITDA 1.73x1.84x2.96x2.10x1.06x1.64x3.51x5.35x10.90x2.66x2.77x3.05x5.24x2.56x0.84x1.42x
Current ratio 1.73x1.39x1.55x1.57x1.83x1.65x1.49x1.29x1.31x1.13x1.48x1.24x1.19x1.34x1.48x1.36x

The current year, quarter by quarter

As the company filed it in its interim report. The fourth quarter does not exist on its own in that filing — the closed year comes in the annual one, and we do not derive a Q4, so that a figure we computed never sits beside the figures the company reported. Filed on is the date the report became public, and the price is taken from it.

quarterrevenueprofitnet marginP/E TTMP/Bfiled on
2024T1!13,377.5593.74.4%-56.71.822024-05-07
2024T214,929.61,093.97.3%21.02.482024-08-14
2024T315,522.71,136.57.3%12.52.472024-11-13
2025T115,512.01,185.17.6%8.62.062025-05-15
2025T215,364.6734.94.8%8.41.792025-08-14
2025T3!16,397.2790.14.8%2025-11-10
2026T1!15,326.7538.83.5%2026-05-14
2026T2!15,967.3545.03.4%2026-08-13

Full series, every quarter: GET /empresas/BRFS3/trimestres

Dividends per year

yearper sharepayments
2025R$ 2.08612
2024R$ 0.70462
2016R$ 0.76412
2015R$ 1.19983
2014R$ 0.94843
2013R$ 0.88353
2012R$ 0.31592
2011R$ 0.72672

Piotroski F-Score 4/9 (2025) — what each criterion means.

Restated filings for this company

The regulator overwrites the old version; we keep both. Figures in R$ millions: first filing on the left, restatement on the right.

fiscal yearaccountfirst filingrestated
2017DRE 3.0133,469.428,314.2
2024BPP 2.02.0116,827.719,574.0
2013DRE 3.0128,401.125,667.3
2013DRE 3.02-21,733.8-19,658.3
2020DFC_MI 6.014,309.85,570.5
2024BPP 2.01.04952.61,800.0
2013DRE 3.036,667.36,009.0
2017DRE 3.035,077.84,564.7

This company appears in

Other companies in Consumer Defensive

26 more with a page, same CVM sector — a classification of the regulator's, not ours.

Take this into your code

Everything on this page is also JSON: GET /empresas/BRFS3/indicadores. WEGE3 is open for testing without a key; for the rest, create a free key (200 calls/day, no card).

Price coverage: 3,899 sessions, 2010-01-04 → 2025-09-22 · methodology · how we verify

Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 10:37 UTC. If this does not match /saude, you are reading a cached copy.